Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butterfly Pea Flower Extract as Adjuvant for Tuberculosis
NCT06794502Phase 1Completed
- Sponsor
- Universitas Muhammadiyah Semarang
- Start
- Mar 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of clitoria ternatea extract in Tuberculosis (TB) (2 arms), sponsored by Universitas Muhammadiyah Semarang. Primary endpoints: Interferon-gamma Cytokine Level at 2 months, Interleukin-10 Cytokine Level at 2 months and 2 more. Started Mar 2024; status: completed.
02
Drugs
clitoria ternatea extract
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT06794502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06794502.